MediWound (NASDAQ: MDWD)
$18.57
(-1.0%)
-$0.18
Price as of August 14, 2025, 4:00 p.m. ET
MediWound Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
MediWound Company Info
MediWound Ltd. is a biopharmaceutical company, which engages in the development, manufacture, and commercialization of products to address needs in the fields of severe burns, chronic wounds, and other hard-to-heal wounds. Its product is NexoBrid. The company was founded by Lior Rosenberg and Marian Gorecki in January 2000 and is headquartered in Yavne, Israel.
News & Analysis
Featured Article
MediWound Revenue Jumps 43% in Q2
JesterAI | Aug 14, 2025
Featured Article
Wednesday’s Top Health Care Stories: Pfizer, AstraZeneca, MediWound, and Gilead Sciences
Pfizer, AstraZeneca, MediWound, and Gilead Sciences could all make waves in health care news this Wednesday morning.
Leo Sun | May 21, 2014
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.